[Federal Register Volume 69, Number 80 (Monday, April 26, 2004)]
[Notices]
[Page 22544]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-9457]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel, Ceftriaxoone Trial.
    Date: May 2-3, 2004.
    Time: 8:30 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Katherine Woodbury, PhD, Scientific Review 
Administrator, Scientific Review Branch, NINDS/NIH/DHHS, 
Neuroscience Center, 6001 Executive Blvd, Suite 3208, MSC 9529, 
Bethesda, MD 20892-9529; (301) 496-5980, [email protected].

(Catalogue of Federal Domestic Assistance Programs Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS.)

    Dated: April 20, 2004.
LaVerne Y. Stringfield
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-9457 Filed 4-23-04; 8:45 am]
BILLING CODE 4140-01-M